Sanjiv Patel
President and CEO at Relay Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Relay Therapeutics Inc., 3 years.
Relay Therapeutics Inc.
Director · President and CEO
Chief executive roles
Relay Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Relay Therapeutics Inc. | Open-market sale | −48,199 | $18.94 | $912,889 |
| Aug 17, 2026 | Relay Therapeutics Inc. | Open-market sale | −48,199 | $20.33 | $979,886 |
| Jul 7, 2026 | Relay Therapeutics Inc. | Open-market sale | −48,199 | $19.58 | $943,736 |
| Jun 30, 2026 | Relay Therapeutics Inc. | Grant or award | +3,056 | $6.95 | $21,239 |
| Jan 6, 2026 | Relay Therapeutics Inc. | Open-market sale | −43,168 | $7.82 | $337,574 |
| Dec 31, 2025 | Relay Therapeutics Inc. | Grant or award | +994 | $2.99 | $2,972 |
| Nov 3, 2025 | Relay Therapeutics Inc. | Open-market sale | −62,073 | $7.00 | $434,511 |
| Jul 9, 2025 | Relay Therapeutics Inc. | Open-market sale | −42,740 | $3.57 | $152,582 |
| Jul 9, 2025 | Relay Therapeutics Inc. | Open-market sale | −18,639 | $3.57 | $66,541 |
| Jun 30, 2025 | Relay Therapeutics Inc. | Grant or award | +5,000 | $2.94 | $14,700 |
| Apr 23, 2025 | Relay Therapeutics Inc. | Open-market sale | −42,769 | $2.97 | $127,024 |
| Apr 23, 2025 | Relay Therapeutics Inc. | Open-market sale | −18,653 | $2.97 | $55,399 |
| Feb 13, 2025 | Relay Therapeutics Inc. | Open-market sale | −75,324 | $3.70 | $278,699 |
| Feb 11, 2025 | Relay Therapeutics Inc. | Open-market sale | −140,182 | $3.85 | $539,701 |
| Feb 11, 2025 | Relay Therapeutics Inc. | Grant or award | +332,465 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.